Company Filing History:
Years Active: 2002
Title: Kevin Buckman: Innovator in Breast Cancer Detection
Introduction
Kevin Buckman, an inventive mind based in Stockton, California, has made significant contributions to the field of medical technology. His expertise and innovative spirit are reflected in his patent, which focuses on the early detection of breast cancer—a critical advancement in women's health.
Latest Patents
Kevin Buckman's patent, titled "Method and Apparatus for Detection of Cancerous and Precancerous Conditions in a Breast," outlines an advanced system for identifying precancerous and cancerous conditions. This innovative apparatus includes a computer designed to digitize mammogram and scinti-mammogram image data. The system utilizes computer-based software that manipulates these digitized images, allowing for the generation of region of interest (ROI) images. These images provide essential insights regarding precancerous and cancerous conditions, enhancing the diagnostic process. Furthermore, the setup ensures that both the mammogram and scinti-mammogram data are displayed concurrently, allowing for comprehensive visual analysis.
Career Highlights
Currently, Kevin is associated with Lifeline Biotechnologies, Inc., where his role focuses on leveraging technology to improve diagnostic processes in the healthcare sector. His commitment to innovation continues to push boundaries in medical imaging and breast cancer detection, showcasing how technology can intervene in critical areas of health.
Collaborations
Throughout his career, Kevin has worked alongside talented colleagues, including Abdou F. Deban and David M. Tumey. Their collaborative efforts contribute to a dynamic work environment aimed at ensuring advancements in medical technology and patient care.
Conclusion
Kevin Buckman’s innovative contributions underscore the importance of technology in the early detection of breast cancer. His patent represents a vital step forward in medical diagnostics, reflecting his dedication to improving health outcomes for women. As he continues to work with Lifeline Biotechnologies, Buckman's vision and expertise promise to lead to further advancements in this critical field.